AU2011302137A1 - Methods of converting a patient's treatment regimen from intravenous administration of an opioid to oral co-administration of morphine and oxycodone using a dosing algorithm to provide analgesia - Google Patents

Methods of converting a patient's treatment regimen from intravenous administration of an opioid to oral co-administration of morphine and oxycodone using a dosing algorithm to provide analgesia Download PDF

Info

Publication number
AU2011302137A1
AU2011302137A1 AU2011302137A AU2011302137A AU2011302137A1 AU 2011302137 A1 AU2011302137 A1 AU 2011302137A1 AU 2011302137 A AU2011302137 A AU 2011302137A AU 2011302137 A AU2011302137 A AU 2011302137A AU 2011302137 A1 AU2011302137 A1 AU 2011302137A1
Authority
AU
Australia
Prior art keywords
dose
morphine
oxycodone hydrochloride
morphine sulfate
oxycodone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2011302137A
Other languages
English (en)
Inventor
Laurel J. Mengle-Gaw
Patricia T. Richards
Benjamin D. Schwartz
Warren C. Stern
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
QRxPharma Ltd
Original Assignee
QRxPharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US12/881,677 external-priority patent/US7923453B1/en
Priority claimed from US12/881,728 external-priority patent/US8012990B2/en
Priority claimed from US13/185,016 external-priority patent/US8222267B2/en
Application filed by QRxPharma Ltd filed Critical QRxPharma Ltd
Publication of AU2011302137A1 publication Critical patent/AU2011302137A1/en
Assigned to QRxPharma Ltd. reassignment QRxPharma Ltd. Amend patent request/document other than specification (104) Assignors: QRxPharma Ltd.
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2011302137A 2010-09-14 2011-09-14 Methods of converting a patient's treatment regimen from intravenous administration of an opioid to oral co-administration of morphine and oxycodone using a dosing algorithm to provide analgesia Abandoned AU2011302137A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US12/881,677 US7923453B1 (en) 2009-10-14 2010-09-14 Methods of converting a patient's treatment regimen from intravenous administration of an opioid to oral co-administration of morphine and oxycodone using a dosing algorithm to provide analgesia
US12/881,677 2010-09-14
US12/881,728 2010-09-14
US12/881,728 US8012990B2 (en) 2009-10-14 2010-09-14 Methods of converting a patient's treatment regimen from intravenous administration of an opioid to oral co-administration of morphine and oxycodone using a dosing algorithm to provide analgesia
US13/185,016 US8222267B2 (en) 2009-10-14 2011-07-18 Methods of converting a patient's treatment regimen from intravenous administration of an opioid to oral co-administration of morphine and oxycodone using a dosing algorithm to provide analgesia
US13/185,016 2011-07-18
PCT/US2011/051577 WO2012037239A1 (en) 2010-09-14 2011-09-14 Methods of converting a patient's treatment regimen from intravenous administration of an opioid to oral co-administration of morphine and oxycodone using a dosing algorithm to provide analgesia

Publications (1)

Publication Number Publication Date
AU2011302137A1 true AU2011302137A1 (en) 2013-05-02

Family

ID=44903337

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2011302137A Abandoned AU2011302137A1 (en) 2010-09-14 2011-09-14 Methods of converting a patient's treatment regimen from intravenous administration of an opioid to oral co-administration of morphine and oxycodone using a dosing algorithm to provide analgesia

Country Status (7)

Country Link
EP (1) EP2616075A1 (enExample)
JP (1) JP2013537232A (enExample)
CN (1) CN103415291A (enExample)
AU (1) AU2011302137A1 (enExample)
CA (1) CA2811285A1 (enExample)
WO (1) WO2012037239A1 (enExample)
ZA (1) ZA201302585B (enExample)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPN603895A0 (en) 1995-10-19 1995-11-09 University Of Queensland, The Production of analgesic synergy by co-administration of sub-analgesic doses of two strong opioids
US20050053659A1 (en) 2003-09-10 2005-03-10 Pace Gary W. Methods and compositions for reducing the risk associated with the administration of opioid analgesics in patients with diagnosed or undiagnosed respiratory illness
US20090291975A1 (en) 2008-05-20 2009-11-26 Warren Stern Dual opioid pain therapy
US8012990B2 (en) * 2009-10-14 2011-09-06 QRxPharma Ltd. Methods of converting a patient's treatment regimen from intravenous administration of an opioid to oral co-administration of morphine and oxycodone using a dosing algorithm to provide analgesia
US7923453B1 (en) * 2009-10-14 2011-04-12 QRxPharma Ltd. Methods of converting a patient's treatment regimen from intravenous administration of an opioid to oral co-administration of morphine and oxycodone using a dosing algorithm to provide analgesia
US20170123700A1 (en) 2015-11-03 2017-05-04 Samsung Electronics Co., Ltd. Io redirection methods with cost estimation

Also Published As

Publication number Publication date
WO2012037239A1 (en) 2012-03-22
CN103415291A (zh) 2013-11-27
CA2811285A1 (en) 2012-03-22
EP2616075A1 (en) 2013-07-24
JP2013537232A (ja) 2013-09-30
ZA201302585B (en) 2014-05-28

Similar Documents

Publication Publication Date Title
AU2006217870B2 (en) Dosage form containing oxycodone and naloxone
DK2574167T3 (en) LIQUID NOSE SPRAY CONTAINING low-dose naltrexone
CA2678582A1 (en) Improvements in and relating to medicinal compositions
WO2012056402A2 (en) Formulations and methods for attenuating respiratory depression induced by opioid overdose
CA2678568C (en) Improved medicinal compositions comprising buprenorphine and nalmefene
KR101971412B1 (ko) 정맥 내 투여용 이부프로펜의 투여
CN106999454A (zh) 共同施用静脉内布洛芬和对乙酰氨基酚以治疗疼痛
US7923453B1 (en) Methods of converting a patient's treatment regimen from intravenous administration of an opioid to oral co-administration of morphine and oxycodone using a dosing algorithm to provide analgesia
US8012990B2 (en) Methods of converting a patient's treatment regimen from intravenous administration of an opioid to oral co-administration of morphine and oxycodone using a dosing algorithm to provide analgesia
US8222267B2 (en) Methods of converting a patient's treatment regimen from intravenous administration of an opioid to oral co-administration of morphine and oxycodone using a dosing algorithm to provide analgesia
EP2616075A1 (en) Methods of converting a patient's treatment regimen from intravenous administration of an opioid to oral co-administration of morphine and oxycodone using a dosing algorithm to provide analgesia
US20250345324A1 (en) Combination formulations of naloxone and atipamezole
AU2011254554B2 (en) Liquid nasal spray containing low-dose naltrexone
JP2005533046A (ja) 鎮痛薬の作用を増強するためにオピオイド鎮痛薬と併用するデバゼピドの使用
Ikomi et al. Opioid Antagonists
HK1235300A1 (en) Co-administration of intravenous ibuprofen and acetaminophen for treatment of pain
HK1168000A (en) Administration of intravenous ibuprofen

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application